fluorodeoxyglucose f18 has been researched along with galantamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amezcua, H; Carter, MF; Chow, G; Cummings, JL; Davoodi, P; Dinov, ID; Mega, MS; O'Connor, SM; Porter, V; Reback, E | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and galantamine
Article | Year |
---|---|
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Brain; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Functional Laterality; Galantamine; Humans; Imaging, Three-Dimensional; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Nootropic Agents; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2005 |